Filing Details

Accession Number:
0001127602-12-026744
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-20 12:34:43
Reporting Period:
2012-09-19
Filing Date:
2012-09-20
Accepted Time:
2012-09-20 12:34:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884731 Ariad Pharmaceuticals Inc ARIA Biological Products, (No Disgnostic Substances) (2836) 223106987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1461612 M Daniel Bollag C/O Ariad Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge MA 02139
Sr. Vp, Reg. Affairs & Quality No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-09-19 7,500 $1.30 93,019 No 4 M Direct
Common Stock Disposition 2012-09-19 7,500 $24.00 85,519 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2012-09-19 7,500 $0.00 7,500 $1.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,000 2009-03-10 No 4 M Direct
Footnotes
  1. Shares were aquired upon the exercise of outstanding stock options at $1.30 per share.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2012.
  3. Options vest 25% per year on each March 10, 2010, 2011, 2012 and 2013.